Queena Han - 19 Nov 2021 Form 4 Insider Report for XBiotech Inc. (XBIT)

Reporting relationship: VP Finance & HR
Issuer ticker: XBIT
Reported as of: 19 Nov 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Nov 2021, 15:10:37 UTC
Source filing: View source filing
Reporting owner signature: Queena Han

Key filing fact

Queena Han filed Form 4 for XBiotech Inc. (XBIT) on 23 Nov 2021.

Key facts

This page summarizes Queena Han's Form 4 filing for XBiotech Inc. (XBIT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Nov 2021, 15:10.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XBIT transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +35,000
Change %
Price: $0.000000
Shares after: 35,000
Date: 19 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $12.67

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

On November 19, 2021 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.